People on the move
Brammer Bio has named Christopher Murphy as its new chief manufacturing officer.
The contract development and manufacturing organization (CDMO) recently launched its commercial gene therapy manufacturing operation in Cambridge, MA and is expanding its clinical capacity in Alachua, FL.
Mark Bamforth, Brammer's president and CEO said Murphy will bring a blend of commercial and clinical manufacturing experience.
Murphy was at Sanofi-Genzyme for the past 16 years where he was most recently the general manager of the company’s Allston Landing commercial biologics facility in Boston, MA.